Hepatitis C virus-related hepatocellular carcinoma and B-cell lymphoma patients show a different profile of major histocompatibility complex class II alleles.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Human Immunology

• Publication date

  2004-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.HUMIMM.2004.08.183PMID 15556690
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia.

  2010cited by this paper
• Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source

  2004cited by this paper
• Extended human leukocyte antigen haplotype EH18.1 influences progression to hepatocellular carcinoma in patients with hepatitis C virus infection.

  2004cited by this paper
• Non‐Hodgkin's lymphoma and hepatitis C virus: A case‐control study from northern and southern Italy

  2004cited by this paper
• Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study.

  2003cited by this paper
• Primary lymphoma of the liver: Clinical‐pathological features and relationship with HCV infection in French patients

  2003cited by this paper
• Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response.

  2003cited by this paper
• MHC class II‐expressing hepatocytes function as antigen‐presenting cells and activate specific CD4 T lymphocyutes

  2003cited by this paper
• Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease.

  2002cited by this paper
• Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels

  2002cited by this paper
• Lack of Hcv Infection in Malignant, Cells Refutes the Hypothesis of a Direct Transforming Action of the Virus in the Pathogenesis of Hcv-Associated B-Cell Nhls

  2002cited by this paper
• B and C hepatitis viruses, HLA-DQ1 and -DR3 alleles and autoimmunity in patients with hepatocellular carcinoma.

  2002cited by this paper
• Rheumatoid factors: host resistance or autoimmunity?

  2002cited by this paper
• Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease

  2001cited by this paper
• [Non-Hodgkin's lymphoma and hepatitis C virus].

  2001cited by this paper
• Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma.

  2001cited by this paper
• Immune control of HIV: the obstacles of HLA and viral diversity

  2001cited by this paper
• Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia.

  2000cited by this paper
• HLA association with hepatitis C virus infection.

  2000cited by this paper
• Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.

  2000cited by this paper
• 13 Hepatitis C and hepatocellular carcinoma

  2000cited by this paper
• Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death

  2000cited by this paper
• Pre‐malignant and malignant lymphoproliferations in an HCV‐infected type II mixed cryoglobulinemic patient are sequential phases of an antigen‐driven pathological process

  2000cited by this paper
• Mouse Liver Tumorigenesis: Models, Mechanisms, and Relevance to Human Disease

  1999cited by this paper
• HLA class II favors clearance of HCV infection and progression of the chronic liver damage.

  1999cited by this paper
• Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research.

  1999cited by this paper
• Human leukocyte antigen class II and III alleles and severity of hepatitis C virus–related chronic liver disease

  1999cited by this paper
• Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia.

  1998cited by this paper
• Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.

  1998cited by this paper
• Association between MHC class II alleles and clearance of circulating hepatitis C virus. Members of the Trent Hepatitis C Virus Study Group.

  1998cited by this paper
• Hepatitis C

  1998cited by this paper
• Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia.

  1998cited by this paper
• Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection.

  1997cited by this paper
• Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1‐associated cytokines

  1996cited by this paper
• Hepatitis C and Hepatocellular Carcinoma

  1995cited by this paper
• MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation.

  1994cited by this paper
• Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage.

  1994cited by this paper
• HLA DR–DQ associations with cervical carcinoma show papillomavirus–type specificity

  1994cited by this paper
• A role for hepatitis C virus infection in type II cryoglobulinemia.

  1992cited by this paper
• Primary lymphoma of the liver

  1988cited by this paper
• The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.

  1987cited by this paper
• Cryoglobulinemia in chronic liver diseases.

  1980cited by this paper
• Statistical methods in cancer research: volume 1- The analysis of case-control studies

  1980cited by this paper

• Human Leukocyte Antigen (HLA) and Tumor Immunity: A Critical Link in Cancer Immunotherapy

  2026cites this paper
• Human leukocyte antigen and tumor immunotherapy (Review)

  2023cites this paper
• Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review.

  2020cites this paper
• Immunogenetics of Cancer

  2020cites this paper
• Sex-specific survival difference in association with HLA-DRB1∗04 following allogeneic haematopoietic stem cell transplantation for lymphoid malignancies.

  2018cites this paper
• Genome-wide association pathway analysis to identify candidate single nucleotide polymorphisms and molecular pathways associated with TP53 expression status in HBV-related hepatocellular carcinoma

  2018influential citation
• Genetic susceptibility of eight nonsynonymous polymorphisms in HLA-DRB1 gene to hepatocellular carcinoma in Han Chinese

  2016cites this paper
• Associations of human leucocyte antigen class II‐DQB1 alleles with hepatitis C virus infection in Egyptian population: a multicentre family‐based study

  2016cites this paper
• Intravascular large B-cell lymphoma associated with silicone breast implant, HLA-DRB1*11:01, and HLA-DQB1*03:01 manifesting as macrophage activation syndrome and with severe neurological symptoms: a case report

  2016cites this paper
• Association of HLA-DRB1 gene polymorphisms with hepatocellular carcinoma risk: a meta-analysis.

  2016cites this paper
• Human leukocyte antigen class II DQB 1 * 0301 , DRB 1 * 1101 alleles and spontaneous clearance of hepatitis C virus infection : A meta-analysis

  2014cites this paper
• Molecular Signature in HCV-Positive Lymphomas

  2012cites this paper
• Immune-Related Disorders and Extrahepatic Diseases in Chronic HCV Infection

  2012cites this paper
• [Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection].

  2011cites this paper
• HLA Class II Alleles and Chronic Hepatitis C Virus Infection

  2011cites this paper
• Specific HLA-DQB1 alleles associated with risk for development of hepatocellular carcinoma: a meta-analysis.

  2011cites this paper
• Association between HLA-DRB1 alleles polymorphism and hepatocellular carcinoma: a meta-analysis

  2010cites this paper
• HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin's lymphoma is related to the type II mixed cryoglobulinemia.

  2010cites this paper
• Human major histocompatibility complex (MHC)-region gene and haplotype polymorphisms in non-Hodgkin’s lymphoma

  2009cites this paper
• Associazione tra genotipo virale, HLA e manifestazioni extra-epatiche dell'epatite C* Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection

  2008cites this paper
• Concomitant diffuse large B‐cell lymphoma and hepatocellular carcinoma in chronic hepatitis C virus liver disease: A study of two cases

  2008cites this paper
• HLA-Class II Alleles in Egyptian Patients with Hepatocellular Carcinoma

  2008cites this paper
• Coexistence of splenic marginal zone lymphoma with hepatocellular carcinoma: a case report

  2007influential citation
• A comparative review of HLA associations with hepatitis B and C viral infections across global populations.

  2007cites this paper
• Role of the HLA Class II

  2007cites this paper
• Evaluating Replication-Defective Vesicular Stomatitis Virus as a Vaccine Vehicle

  2006cites this paper
• El sistema de antígenos leucocitarios humanos de clase II y la infección causada por el virus de la hepatitis C

  2006cites this paper
• Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses.

  2006cites this paper
• Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: a meta-analysis.

  2005cites this paper
• Enhanced TH1 cytokine production in hepatitis C virus-infected patients with mixed cryoglobulinemia: understanding the pathological issues.

  2004cites this paper